CompoAtlas

Complexe de macérats miellés de bourgeons - Lâcher prise

Food supplement declared in France, decision dated 18 September 2025

Complexe de macérats miellés de bourgeons - Lâcher prise (Cybèle nature) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Rosa canina 0.1 g per day, Abies alba 0.1 g per day, Tilia platyphyllos 0.1 g per day, Ficus carica 0.1 g per day, Crataegus monogyna 0.1 g per day. None of the rules we check flags an issue with its declared composition.

Brand
Cybèle nature
Food business operator placing the product on the market
E.I Cybèle nature
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Dropper
Daily dose
0,1 g
Directions for use
5 à 30 gouttes par jour, diluées dans un verre d’eau, en dehors des repas pendant 21 jours.
Intended populations
Adolescents aged 11 to 17, Men and women aged 18 and over, People over 60
Not recommended (according to the manufacturer)
Breastfeeding women, Children (under 12), Pregnant women, Taking anticoagulants, Taking blood pressure medication
Objectives stated by the manufacturer (these are not authorised claims)
Mood

Declaration 341627, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Rosa canina L.Jeune pousseMacérât hydroalcoolique0.1 g
Abies alba Mill.BourgeonMacérât hydroalcoolique0.1 g
Tilia platyphyllos Scop.Feuille (bourgeon)Macérât hydroalcoolique0.1 g
Ficus carica L.BourgeonMacérât hydroalcoolique0.1 g
Crataegus monogyna Jacq.Feuille (bourgeon)Macérât hydroalcoolique0.1 g

Other active ingredients

NamePer day
mielnot declared

Other ingredients

eau, Alcool

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Inadapté aux enfants âgés de moins de 12 ans. Déconseillé en cas de traitement anti-inflammatoire, prise de fluidifiant sanguin, aspirine. Déconseillé chez la femme enceinte et en cas d’allaitement.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Tilia platyphyllos Scop.
    Read the warning, when it applies and the studies cited

    Linden - TILIA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Mills and Bone 2005; De Smet 1993).

    Sources cited by Health Canada (2)
    • De Smet PAGM, Keller K, Hansel R, Chandler RF, editors. Adverse Effects of Herbal Drugs, Volume 2. Berlin (DE): Springer-Verlag; 1993.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

  • Crataegus monogyna Jacq.
    Read the warning, when it applies and the studies cited

    Hawthorn

    Route of administration: Oral (ESCOP 2009; Bradley 2006; Mills and Bone 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking cardiac glycosides (e.g., digoxin) or blood pressure or heart medications (Brinker 2010; Bradley 2006).

    Sources cited by Health Canada (2)
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association; 2006.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have chest pain, irregular heartbeat, or shortness of breath.

    Health Canada monograph dated 31 July 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : Cybèle nature

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Complexe de macérats miellés de bourgeons - Lâcher prise (Cybèle nature): composition and regulation”, https://compoatlas.com/en/supplements/products/341627-complexe-de-macerats-mielles-de-bourgeons-lacher-prise, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line